Evidence map›Paper›PMID 18721224›Full record

Trial reportJournal of the American Geriatrics Society2008

The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis.

Mark L Unruh, Anne B Newman, Brett Larive, Mary Amanda Dew, Dana C Miskulin, Tom Greene, Srinivasan Beddhu, Michael V Rocco, John W Kusek, Klemens B Meyer and 1 more

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Geriatrics Society, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Quality of life may be a more valuable prognostic factor than depression in older hemodialysis patients.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020
    Article
  5. Article
  6. Article
  7. Review
  8. Quality of Life-Repeated Measurements Are Needed In Dialysis Patients.Open access Macedonian journal of medical sciences · 2018
    Article
  9. Article
  10. Differences in quality of life between Jewish and Arab patients on hemodialysis.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2017
    Article
  11. Article
  12. Change in quality of life and one-year mortality risk in maintenance dialysis patients.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2016
    Article
  13. Article
  14. Article
  15. Chronic kidney disease and the aging population.Journal of cross-cultural gerontology · 2014
    Article
  16. Should an elderly patient with stage V CKD and dementia be started on dialysis?Clinical journal of the American Society of Nephrology : CJASN · 2014
    Article
  17. Chronic kidney disease and the aging population.Indian journal of nephrology · 2014
    Article
  18. Article
  19. Review
  20. Chronic kidney disease and the aging population.International journal of organ transplantation medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Mark L UnruhDepartment of Medicine, University of Pittsburgh, Pennsylvania, USA. unruh@pitt.edu
Anne B Newman
Brett Larive
Mary Amanda Dew
Dana C Miskulin
Tom Greene
Srinivasan Beddhu
Michael V Rocco
John W Kusek
Klemens B Meyer
Hemodialysis Study Group
University of Utah · USCleveland Clinic · USTufts Medical Center · USAmerican Institute of Biological Sciences · USWake Forest University · US

Funding

HEMODIALYSIS OUTCOME STUDY--DATA COORDINATING CENTERU01DK046143 · NIDDK · CLEVELAND CLINIC FOUNDATION · PI BECK, GERALD J · 1992 to 2005
$3.1M
Impact of Nocturnal Hemodialysis on Sleep Apnea, Sleep Quality & Daytime SymptomsR01DK077785 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI UNRUH, MARK LYNN · 2007 to 2011
$1.3M
Sleep and Daytime Functioning in Chronic Kidney DiseaseK23DK066006 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI UNRUH, MARK LYNN · 2004 to 2008
$710k
MORTALITY AND MORBIDITY IN MEMODIALYSIS PATIENTS TRIALU01DK046126 · NIDDK · BETH ISRAEL MEDICAL CTR (NEW YORK) · PI LEVIN, NATHAN W · 1992 to 2001
$635k
MORTALITY &MORBIDITY IN HEMODIALYSIS PATIENTSU01DK049241 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DAUGIRDAS, JOHN T · 1994 to 2001
$584k
CLINICAL OUTCOME OF HEMODIALYSIS IN UTAHU01DK049252 · NIDDK · UNIVERSITY OF UTAH · PI CHEUNG, ALFRED K. · 1994 to 2001
$538k
MMHD CLINICAL CENTERU01DK049271 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ROCCO, MICHAEL V · 1994 to 2001
$477k
MORTALITY AND MORBIDITY IN HEMODIALYSIS STUDY PROTOCOLU01DK049259 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI MILFORD, EDGAR L · 1994 to 2001
$430k
REDUCTION IN MORTALITY &MORBIDITY IN HEMODIALYSISU01DK046114 · NIDDK · VANDERBILT UNIVERSITY · PI SCHULMAN, GERALD · 1992 to 2001
$429k
MULTIINTERVENTION TRIAL IN HEMODIALYSIS PATIENTSU01DK046109 · NIDDK · TUFTS MEDICAL CENTER · PI LEVEY, ANDREW S · 1992 to 2001
$406k
MORTALITY AND MORBIDITY IN HEMODIALYSIS--CLINICAL CENTERU01DK049261 · NIDDK · UNIVERSITY OF ROCHESTER · PI ORNT, DANIEL B. · 1994 to 2001
$392k
MORBIDITY AND MORTALITY IN HEMODIALYSIS PATIENTSU01DK049244 · NIDDK · DUKE UNIVERSITY · PI BERKOBEN, MICHAEL S · 1994 to 2001
$386k
NIDDK NIH HHS DK077785NIDDK NIH HHS DK66006NIDDK NIH HHS K23 DK066006NIDDK NIH HHS R01 DK077785NIDDK NIH HHS U01 DK046143NIDDK NIH HHS U01DK 46109NIDDK NIH HHS U01 DK 46114NIDDK NIH HHS U01DK 46126NIDDK NIH HHS U01DK 46143NIDDK NIH HHS U01DK 49240NIDDK NIH HHS U01DK49241NIDDK NIH HHS U01DK 49243NIDDK NIH HHS U01DK, 49244NIDDK NIH HHS U01DK 49249NIDDK NIH HHS U01DK 49252NIDDK NIH HHS U01DK 49254NIDDK NIH HHS U01DK49259NIDDK NIH HHS U01DK 49261NIDDK NIH HHS U01DK 49264NIDDK NIH HHS U01DK 49271NIDDK NIH HHS UO1DK 49242
6 · The paper itself

Abstract

objectivesTo assess the extent to which persons aged 70 and older undergoing hemodialysis (HD) had greater changes in health-related quality of life (HRQOL) over 3 years than younger patients undergoing HD.

designLongitudinal.

settingThe Hemodialysis Study (HEMO Study) was a randomized, clinical trial of the effects of HD dose and membrane flux on mortality and morbidity in patients undergoing chronic dialysis.

participantsSecondary analysis of the HEMO Study. MEASUREMENTS: Participants completed the Index of Well-Being (IWB) and the Kidney Disease Quality of Life-Long Form (KDQOL-LF), which also includes the Medical Outcomes Study 36-item Short Form Questionnaire (SF-36) annually. Changes in subjects those aged 70 and older were compared with changes in subjects aged 55 to 69 and 18 to 54.

resultsAt baseline, 1,813 (98%) of HEMO participants completed HRQOL surveys. Their mean age was 58, 56% were female, 64% were black, and mean duration of dialysis was 3.8 years. In subjects with HRQOL data at the first three annual assessments, there were no substantial mean declines in the SF-36 Physical or Mental Component Summary scales over 3 years. In models incorporating effects of attrition, the differences in average change over 3 years between patients undergoing HD aged 70 and older and the younger cohorts were small in magnitude. There were high rates of adverse HRQOL events in all age groups and significantly higher composite event rates of death or clinically significant decline in HRQOL over 3 years was found in subjects aged 70 and older.

conclusionAlthough HRQOL was impaired in the population undergoing HD, HRQOL scores at baseline reflect a better-preserved multidimensional quality of life in respondents in the HEMO Study aged 70 and older than in younger patients undergoing HD. There was no substantial relationship between age and average decline in HRQOL score over 3 years in participants in the HEMO Study.

Indexed as

AdolescentAdultAgedAge FactorsCohort StudiesDiabetic NephropathiesFemaleFollow-Up StudiesHumansHypertensionKidney Failure, ChronicMaleMiddle AgedOutcome Assessment, Health CareQuality of LifeReference Values

Identifiers

PMID18721224
PMCPMC6590685
OpenAlexW2116051138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.